pirinixic acid has been researched along with endothelin-1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delerive, P; Duriez, P; Fruchart, JC; Furman, C; Kandoussi, A; Martin-Nizard, F; Staels, B | 1 |
| Bulhak, AA; Edvinsson, L; Pernow, J; Sjöquist, PO; Xu, CB | 1 |
| Guo, Y; Huang, D; Liu, H; Xu, H; Zhao, Q | 1 |
3 other study(ies) available for pirinixic acid and endothelin-1
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cells.
Topics: Animals; Cattle; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Lipoproteins, LDL; Oxidation-Reduction; Peroxisome Proliferators; Protein Kinase C; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Topics: Animals; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Heart Rate; Immunoblotting; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; PPAR alpha; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
PPAR-α Agonist WY-14643 Inhibits LPS-Induced Inflammation in Synovial Fibroblasts via NF-kB Pathway.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Chemokine CCL2; Dinoprostone; Endothelin-1; Fibroblasts; Humans; Intercellular Adhesion Molecule-1; Interleukin-1beta; Joint Capsule; Lipopolysaccharides; NF-kappa B; Nitric Oxide; Osteoarthritis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Pyrimidines; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |